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Abstract 
 
Objective: Oxidative stress has been suggested to increase after electroconvulsive therapy (ECT); a 
treatment which continues to be the most effective for severe depression. Oxidative stress could 
potentially be mechanistically involved in both the therapeutic effects and side-effects of ECT.  
 
Methods: We measured sensitive markers of systemic and CNS oxidative stress on DNA and RNA 
(urinary 8-oxodG/8-oxoGuo, cerebrospinal fluid 8-oxoGuo, and brain oxoguanine glycosylase 
mRNA expression) in male rats subjected to electroconvulsive stimulations (ECS); an animal model 
of ECT. Due to previous observations that link hypothalamic-pituitary-adrenal (HPA)-axis activity 
and age to DNA/RNA damage from oxidation, groups of young and middle-aged male animals 
were included, and markers of HPA-axis activity were measured.  
 
Results: ECS induced weight loss, corticosterone increases (only in middle-aged animals), and 
decreased cerebral glucocorticoid receptor mRNA expression, while largely leaving the markers of 
systemic and CNS DNA/RNA damage from oxidation unaltered.  
 
Conclusion: These results suggest that ECS is not associated with any lasting effects on oxidative 
stress on nucleic acids neither in young or middle-aged rats. 
 
Key words: Electroconvulsive stimulations; HPA-axis; oxidative stress; nucleic acids; DNA repair. 
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Significant outcomes 
 
1) We tested if young and middle-aged male rats subjected to an animal model of ECT (ECS) had 
increased whole-body and brain levels of free radical damage to DNA and RNA.  
2) While ECS caused weight-loss and increased stress hormone (corticosterone) levels, we found no 
evidence that ECS causes increased free radical damage to DNA and RNA.  
3) The study does not support that ECS is associated with any major changes in systemic or CNS 
oxidative stress on nucleic acids. 
 
 
Limitations 
1) We did not include measurements immediately after ECS, and thus we cannot rule out that the 
seizures could cause a transient effect on the parameters investigated.  
2) Direct measures of neuronal 8-oxodG/8-oxoGuo in DNA/RNA were not obtained, and thus we 
potentially could have overlooked a small effect of locally increased oxidative stress in the brain, 
that did not manifest itself in the systemic or CSF markers or affect OGG1 mRNA expression.  
3) The study did not include any behavioral measurement to validate the ECS effects. However, 
ECS treatments did induce weight loss, age-dependent CORT changes, and decreased cerebral 
GluR expression, strongly suggesting that the treatments were effective.  
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Introduction 
 
Electroconvulsive therapy (ECT) continues to be the most effective treatment for severe depression 
and can be life-saving in a range of other acute psychiatric conditions [1-3]. The mechanism 
underlying the powerful clinical effects of ECT continues to be unknown [4]. ECT is associated 
with cognitive side-effects, which is a concern for clinicians and patients, and a major cause of 
treatment discontinuation [5]. However, these side-effects are usually transient [6], and there are no 
indications that ECT causes long-term damage to the brain. On the contrary, on a neuronal level 
ECT causes increased neurogenesis, dendritic growth, and synaptic sprouting [7-9]. A consistent 
finding is that the hippocampus, as well as other areas of the brain, are increased in volume after 
ECT [10, 11]. Many cognitive domains improve beyond baseline levels after ECT, probably due to 
the negative effect on cognition by depression in itself [6], and finally, a new study found no 
evidence that ECT increases the risk for dementia [12]. 
 
Preclinical studies suggest that various markers of oxidative stress, including protein and lipid 
oxidation markers, are increased in the brain after ECT [13, 14], although other studies did not find 
such an association [15, 16]. Such a phenomenon could potentially be causally involved in both the 
antidepressant effects and the cognitive side-effects of ECT. We previously observed an increase in 
systemic RNA damage from oxidation in severely depressed patients after ECT [17]. However, 
many other factors than ECT per se could cause a change in a systemic marker of oxidative stress, 
e.g. increased calorie intake and weight gain following the relief of depressive symptoms.  
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Hence, in the present study, we wished to test whether systemic and central nervous system (CNS) 
markers of oxidative damage to DNA/RNA would increase in a preclinical model of ECT 
(electroconvulsive stimulations, ECS). We measured urinary and cerebrospinal fluid (CSF) contents 
of 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxodG) and 8-oxo-7,8-dihydroguanosine (8-oxoGuo) 
by ultraperformance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS). 8-
oxodG/8-oxoGuo are sensitive markers of cellular DNA/RNA damage from oxidation, respectively, 
and their detection by UPLC-MS/MS has been validated by us and others in a range of studies [18-
20]. We also measured the cerebral mRNA expression of a key enzyme in the DNA base excision 
repair pathway, oxoguanine glycosylase 1 (OGG1). Because we and others have previously found 
associations between Hypothalamic-Pituitary-Adrenal (HPA)-axis activity and oxidative stress [21-
23], selected markers of HPA-axis activity were determined. Finally, the role of age, which we 
previously found to modify the association between glucocorticoid and DNA/RNA oxidative stress 
marker excretion [23], was addressed by including a group of young and middle-aged animals, 
respectively.  
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Materials and methods 
 
Animals and housing 
48 male Sprague Dawley rats (Taconic, Denmark) were used for the study: 24 young rats (≈8 weeks 
of age) and 24 retired breeders (7-8 months old). Animals were group housed (two rats per cage) in 
Tecniplast cages (Scanbur, Denmark), 1291H for young animals and 1500U for middle-aged 
animals. Cages were lined with aspen bedding and enriched with aspen nesting material, aspen 
bricks and red polycarbonate rodent huts (Scanbur, Denmark). Food pellets (Altromin 1319, 
Brogaarden, Denmark) and acidified tap water were provided ad libitum. They were kept at a 12 h 
light-dark cycle with 30 min of twilight (lights on at 7 a.m.), temperature at 21 ± 1C and humidity 
at 52 ± 2 %. 
 
General experimental procedure 
Upon arrival, the animals were left to acclimatize for one week. On day eight, animals were single-
housed in metabolic cages for 24 h to obtain baseline food-intake and urine samples. They were 
then, within each age group, matched by weight into two treatment groups (Electroconvulsive 
stimulations (ECS) or sham treatments (SHAM)), yielding four experimental groups: Young 
SHAM animals (Y-SHAM); young ECS animals (Y-ECS); middle-aged SHAM animals (M-
SHAM), and middle-aged ECS animals (M-ECS). The rats then went through a three-week 
treatment period (days 12-30) receiving either ECS or SHAM. On day 34 they were placed in 
metabolic cages for another 24 h. After each 24-h metabolic cage housing, the 24-h food intake was 
recorded and the 24-h calorie intake calculated. The 24 h urine output was weighed and stored at -
80ºC until further analysis. Animals were weighed on treatment days and on days of metabolic cage 
housing.  
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Electroconvulsive stimulations 
Animals received ECS or SHAM (no current in the apparatus) three times per week for three 
consecutive weeks, mimicking a clinical ECT protocol. A unidirectional square wave current (50 
mA, 50 Hz, 10 ms) was administered using forceps electrodes for the ears with a stimulus duration 
of 0.5 s, as previously described [24, 25]. ECS was given between 9AM and 12AM and was 
considered successful when generalized tonic-clonic seizure was induced.  
 
 
CSF sampling, euthanasia and retrieval of brains 
On day 35, animals were anesthetized with an i.p. injection of pentobarbital 200 mg/mL with 
lidocainhydrochloride 20 mg/mL (Glostrup Apotek, Denmark). Under anesthesia, CSF from the rats 
was collected a.m. [26], as previously described [23]. Briefly, after the induction of anesthesia, 
animals were placed in a stereotaxic instrument with the nose tipped downwards at 75º. A 21G 
needle mounted on a needle holder was slowly lowered to puncture the skin at -1.5 mm in the 
anteroposterior plane. CSF was extracted from the cisterna magna into a silicone tube by creation of 
a slight vacuum with a syringe. The CSF was collected in 1.5 ml Eppendorf tubes. The silicone tube 
was cleaned with isotonic sodium chloride and air between each sampling. Samples were kept on 
dry ice and stored at -80ºC until analysis. Immediately following the retrieval of CSF, the animals 
were decapitated; the brains were taken out and snap frozen at -40ºC in isopentane. The frozen 
brains were wrapped in parafilm and stored in individual plastic containers at -80ºC until 
sectioning. 
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In situ hybridization 
In situ hybridization of brain mRNAs was performed as previously described [27]. Briefly, brains 
were cut in 15 μm coronal sections throughout the prefrontal cortex (CTX) (+5.46 mm to +4.20 mm 
relative to bregma, according to Paxinos & Watson 2
nd
 ed.) and dorsal hippocampus (-2.40 mm to -
4.20 mm relative to bregma). Sections were mounted on Superfrost-Plus® slides and hybridized 
with a radiolabelled oligonucleotide probe. A previously used oligonucleotide probe for the 
glucocorticoid receptor (GluR) (DNA Technology, Denmark) was used [25]. The probe had the 
following sequence:  
 
5’-CATATCCTGCATACAACACCTCGGGTTCAATCACCTCC-3’ 
 
For the present study, a new synthetic oligonucleotide OGG1 probe (DNA Technology, Denmark) 
was designed and tested in control tissue before the experiment. The probe had the following 
sequence:  
 
5’-TGGACCAGCCAGGGCATGAAGGTTTGGGAAGCCATGATAA-3’ 
 
Competitive controls with an excess of unlabeled probe were used to test signal specificity. The 
optical density of the radioactive probes was analyzed using the software Scion Image® (RRID: 
SCR_008673). Based on background signal and 
14
C-standards, a calibration curve was determined. 
The densities, expressed as greyscale values in Bq/g, were measured by manually marking the areas 
of interest bilaterally in four sections of the hippocampus, and five sections of the CTX. Areas of 
interest were the dentate gyrus (DG), cornu ammonis (CA) 1, CA3, and CTX. The density data 
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were corrected for background and the average value of the section densities for each of the areas of 
interest was calculated. 
 
Quantification of urinary and cerebrospinal fluid markers 
Corticosterone (CORT), 8-oxodG, and 8-oxoGuo concentrations were determined as previously 
described [23]. Urinary CORT was measured by a commercial ELISA kit (DRG, Germany, RRID: 
AB_2636819). The kit was developed for detection of CORT in serum and plasma, but it has been 
tested by us in several previous studies for the reliable use in urine [23, 28]. The kit is based on a 
polyclonal antibody directed towards an antigenic site on the corticosterone molecule. According to 
the manufacturer, the kit has a mean intra- and inter-assay variability of 3.1% and 6.1%, 
respectively.  
 
Urinary and CSF 8-oxodG and 8-oxoGuo were measured by UPLC-MS/MS. The equipment 
consisted of an Acquity UPLC system connected to a Xevo TQ-S triple quadrupole mass 
spectrometer equipped with a standard electrospray (ESI) inlet probe, all obtained from 
Waters (Waters, Milford, MA, USA). In both methods, stable isotope-labelled 8oxoGuo (M+5) and 
8oxodG (M+5) were used as internal standards. The urinary content of 8-oxodG/8-oxoGuo was 
quantified using a modification of the previously described mass spectrometry method [29]. The 
chromatographic separation was performed on an Acquity UPLC BEH Shield RP18 column (1.7 
μm, 2.1 × 100 mm) from Waters. The column temperature was 4°C. The mass spectrometry 
detection was performed in the negative ionization mode. The MS/MS transition for detection of 
8oxoGuo was m/z 298208, and m/z 282192 for 8oxodG. The CSF samples were added internal 
standards filtered through pre-washed filters (VectaSpin 3 centrifuge filters, 10 K molecular weight 
cut off, Whatman, Kent, UK) before injection. The chromatographic separation was performed on 
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an Acquity UPLC HSS T3 column (1.8 μm, 2.1 x 100 mm) protected with a HSS T3 pre-column 
(1.8 μm, 2.1 x 5 mm) both obtained from Waters. The analytes were separated by gradient elution 
using 0.5 % acetic acid and acetonitrile. The column temperature was 1°C. MS/MS detection was 
performed in the positive ionization mode. The MS/MS transition for detection of 8oxoGuo was 
m/z 300168, and m/z 284168 for 8oxodG. For all the urinary markers, 24 h excretion was 
calculated as nmol/24 h. Although 8-oxodG was detected in some CSF samples, the concentration 
(<1/1000 than the concentration in urine) was below the limit of quantification (≈5 pmol/L) in most 
of the samples, and therefore the CSF 8-oxodG concentration is not reported. 
 
Statistics 
All data were analyzed by two-way analysis of variance (ANOVA) with treatment and age as 
explanatory variables, followed by relevant post-hoc comparisons of groups by independent 
samples t-test in case of significance in the ANOVA. Normality was tested by visual inspection of 
the data distributions. Pearson’s product-moment correlation coefficients were utilized for the 
correlation analyses. Two extreme CSF 8-oxoGuo values (> 2.5 times above the 95 percentile of the 
dataset) were omitted from the analyses. All statistical analyses were performed using the Statistical 
Package for the Social Sciences (SPSS, RRID: SCR_002865) software version 24.0 (IBM 
Corporation, Armonk, NY, USA). Statistical significance was defined as p < 0.05. All statistical 
tests were two-sided. 
 
Ethics 
The study design was approved by the Animal Experiments Inspectorate under the Danish Ministry 
of Food, Agriculture and Fisheries (license number 2012-15-2934-00038). Procedures were 
performed in agreement with the EU directive 2010/63/EU. 
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Results 
 
Two animals (one from each ECS group) were euthanized before the end-point of the experiment 
due to compromised well-being, yielding a total of 11-12 animals in each experimental group. ECS 
caused a significant reduction of body weight gain/weight loss (F(1,42) = 27.41, p < 0.001), which 
was most prominent in the middle-aged animals (p < 0.001). There was no significant effect of ECS 
on 24-h calorie intake (Figure 1).  
 
At both pre- and post-treatment, middle-aged animals had a higher 24-h urinary excretion of CORT 
(F(1,42) = 11.48, p = 0.002, and F(1,42) = 5.20, p = 0.03, respectively). There was a significant effect of 
ECS on the pre-post treatment difference in 24-h excretion of CORT (F(1,42) = 4.74, p = 0.035), and 
a borderline significant interaction between age and treatment (F(1,42) = 3.86, p = 0.056), reflecting a 
significant effect of ECS in middle-aged animals only in the post-hoc test (p = 0.03). There were no 
significant differences between the groups with respect to 24-h 8-oxodG or 8-oxoGuo excretion at 
baseline. Furthermore, there were no significant group differences in the pre-post treatment 
difference of the 24-h excretion of 8-oxodG or 8-oxoGuo (Table 1). 
 
With respect to the CNS markers, we found no effect of age or treatment on CSF 8-oxoGuo 
concentration, but a significant age × treatment interaction (F(1,40) = 4.87, p = 0.033), reflecting a 
trend towards reduced levels after ECS in young animals and increased levels in middle-aged 
animals. However, this was not significant in direct post-hoc comparisons of the groups (Figure 
2A). We found no significant main effects or interactions in the cerebral expression of Ogg1 mRNA 
(Figure 2C). Across all brain areas of interest, and most prominent in the DG and CA1, we found a 
reduction of GluR mRNA expression after ECS in young animals (p < 0.05) (Figure 2D). 
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In exploratory correlation analyses, we found significant correlations between the 24-h urinary 
excretion of CORT and 8-oxoGuo at baseline (r = 0.331, p = 0.02), as well as between the pre-post 
treatment difference in the 24h excretion of CORT and 8-oxoGuo (r = 0.406, p = 0.005). Finally, 
post-treatment 24-h urinary CORT excretion correlated with the CSF 8-oxoGuo concentration (r = 
0.398, p = 0.008) (Figure 3). There were no significant correlations between CORT and 8-oxodG 
(data not shown).  
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Discussion 
 
In the present study, we investigated the effects of ECS on body weight and calorie intake; on 
markers related to the activity of the HPA-axis, as well as on markers of systemic and CNS nucleic 
acid damage from oxidation. ECS caused a significant weight loss or stalling of weight gain, in 
particular in middle-aged animals. This occurred in spite of a sustained 24-h calorie intake. One 
possible interpretation of this finding is that the effect of ECS on body weight is a consequence of a 
peripheral catabolic state induced by increased circulating glucocorticoids [30], rather than a 
centrally mediated reduction in food intake.  
 
At baseline, middle-aged animals had a higher excretion of 24-h CORT, and this is in line with 
existing evidence that the overall glucocorticoid output increases with age [31, 32]. A proposed 
therapeutic mechanism of ECT is normalization of HPA activity [4], but a recent clinical study did 
not find any correlations between baseline salivary cortisol, illness severity and ECT treatment 
response in older, depressed patients [33]. In our study, the excretion of CORT was unaltered by 
ECS in young animals and increased by ECS in middle-aged animals, suggesting that ECS in itself 
causes a biological stress response in older individuals. In young animals, ECS caused a reduction 
in the brain expression of GluR mRNA, and this is a replication of a previous finding [25]. Because 
there was no increase in urinary CORT after ECS in the young animals, the reduced expression of 
GluR is unlikely to be a downregulation caused by negative feedback, but rather a direct effect on 
the brain by ECS per se. It should be noted that we did not include a group of animals with 
experimentally induced depressive symptoms, and thus we cannot conclude on what the net effect 
of ECS on HPA-axis markers in “depressed” animals would be. We have previously found that in 
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animals subjected to chronic restraint stress, concomitant ECS causes a normalization of the 
hippocampal glucocorticoid receptor expression and depressive behavior [25]. 
 
We found no effects of ECS on any of the oxidative stress markers, i.e. urinary 8-oxodG/8-oxoGuo 
excretion, CSF 8-oxoGuo concentration, or cerebral OGG1 RNA expression. Previous studies on 
alternative markers of oxidative stress, e.g. protein oxidation and lipid peroxidation markers, as well 
as antioxidant enzymes, have shown conflicting results. Barichello et al. (2004) found a reduction 
in hippocampal markers of protein and lipid oxidation and an increase in antioxidant enzymes such 
as superoxide dismutase and catalase, both after acute and chronic ECS [15]. In contrast, Feier et al. 
(2006) found increases in the same markers of oxidative stress and decreases in the antioxidant 
enzymes in the hippocampus and striatum after ECS [13].  Finally, using a protocol mimicking 
maintenance ECT, Jornada et al. measured oxidative damage parameters (thiobarbituric acid 
reactive species (TBARS) and protein carbonyls) in the hippocampus, cortex, cerebellum and 
striatum immediately, 48 h and 7 days after the last ECS, and found no alteration in lipid 
peroxidation and protein damage in these four structures [16]. Our study indicates that ECS does 
not cause any significant or lasting changes in systemic or brain DNA/RNA damage from 
oxidation. The major advantage of the markers used in our study compared to e.g. the TBARS and 
protein carbonyls assay, is that they have a much higher specificity for the measured target of 
oxidation (i.e. guanine residues in DNA/RNA) and a high analytical sensitivity and precision [20]. 
The negative findings with respect to effects of ECS are unlikely to be due to insensitivity of the 
markers, which we have previously demonstrated to be sensitive to a range of interventions, 
including induced DNA damage from oxidation [23, 34].  
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Furthermore, we found no effect of age on any of the oxidative stress markers. This is in contrast 
with studies showing increased cellular levels of DNA damage with age (in tissues with limited cell 
proliferation) [35], as well as our own previous finding [23]. However, in the latter study, the old 
animals were 48 weeks of age, whereas the older animals in the present study were only up to 32 
weeks of age. We speculate that this is the main reason why we did not find an age effect in the 
present study.  
 
In exploratory analyses, we found positive correlations between CORT and 8-oxoGuo. This is a 
partial replication of previous findings [22, 36]. The reasons for this correlation between CORT and 
a marker of RNA damage from oxidation are not known. In vitro studies have indicated that CORT 
may induce oxidative stress [37]. However, in a previous study in which we induced a physiological 
increase in circulating CORT, we found a reduction in urinary nucleic acid oxidation markers [23], 
and hence the association does not appear to be a direct or causal one.   
 
Some limitations of the study should be mentioned. We did not include measurements immediately 
after ECS, and thus we cannot rule out that the seizures could cause a transient effect on the 
parameters investigated. Furthermore, we did not include any direct measure of neuronal 8-oxodG 
or 8-oxoGuo, and thus we potentially could have overlooked a small effect of locally increased 
oxidative stress in the brain, that did not manifest itself in the systemic or CSF markers or affect 
OGG1 expression. Because we aimed to study the biochemical effects of ECS rather than those of 
depression, groups of animals with experimentally induced depressive behavior were not included. 
Female animals were not included and the results can not necessarily be extrapolated to females.  
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Finally, the study did not include any behavioral measurement to validate the ECS effects. 
However, ECS treatments did induce weight loss, age-dependent CORT changes, and decreased 
cerebral GluR expression, strongly suggesting that the treatments were effective. 
 
In conclusion, we found that ECS caused a stalling of weight gain and age-dependent changes in 
HPA-axis activity, while largely leaving sensitive and validated markers of systemic and CNS 
DNA/RNA damage from oxidation unaltered. These results suggest that ECS is not associated with 
any lasting effects on oxidative stress on nucleic acids. 
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Figure legends and tables (by order of appearance) 
 
 
 
 
 
Figure 1: Pre-post changes in body weight and calorie intake in young and middle-aged 
animals subjected to electroconvulsive stimulations (ECS): Data are presented as means with 5-
95 percentiles and were analyzed by two-way ANOVA with age and treatment as fixed factors. In 
case of significance in the ANOVA, relevant post-hoc comparisons were performed by independent 
samples t-test. N = 11-12 animals in each group. 
*
 Significant effect of treatment (pyoung = 0.008, 
pmiddle-aged < 0.001). 
**
 Significant effect of age (p < 0.001).  
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Figure 2: Central nervous system markers of HPA-axis activity and nucleic acid damage from 
oxidation in young and middle-aged animals subjected to electroconvulsive stimulations 
(ECS): A: Cerebrospinal fluid concentrations of 8-oxoGuo. B: Representative micrographs of in 
situ hybridization of the glucocorticoid receptor (GluR) and oxoguanine glycosylase (OGG1) 
mRNA in the rat hippocampus (both from a young animal given sham treatments). C+D: mRNA 
expression levels of OGG1 (C) and GluR (D) in the dentate gyrus (DG), CA1, and CA3 area of the 
hippocampus, as well as the frontal cortex (CTX). Data are presented as means with 5-95 
percentiles (A) or 95% confidence intervals (C+D) and were analyzed by two-way ANOVA with 
age and treatment as fixed factors. In case of significance in the ANOVA, relevant post-hoc 
comparisons were performed by independent samples t-test. N = 11-12 animals in each group. 
*
 
Significant effect of treatment (p < 0.05). 
**
 Significant effect of treatment (p < 0.001). 
https://www.cambridge.org/core/terms. https://doi.org/10.1017/neu.2019.7
Downloaded from https://www.cambridge.org/core. Danish National Library of Science and Medicine, on 19 Mar 2019 at 12:52:29, subject to the Cambridge Core terms of use, available at
  28 
 
 
 
 
 
Figure 3: Correlations between corticosterone and 8-oxoGuo in all animals: A: Baseline 
urinary corticosterone (CORT) vs. 8-oxoGuo excretion. B: Pre-post treatment differences in urinary 
CORT vs. 8-oxoGuo excretion. C: Post-treatment urinary CORT excretion vs. CSF 8-oxoGuo 
concentration.  
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Table 1: Urinary markers of HPA-axis activity and nucleic acid damage from oxidation after 
electroconvulsive stimulations: 24-hour urinary excretion of corticosterone (CORT) and 8-
oxodG/8-oxoGuo in young vs. middle-aged rats subjected to electroconvulsive stimulations (ECS) 
or sham treatments (N = 11-12 animals in each group). Values from pre- and post-treatment as well 
the pre-post difference are presented as means (standard deviation) and were analyzed by two-way 
ANOVA with age and treatment as fixed factors. In case if significance in the ANOVA, relevant 
post-hoc comparisons were performed by independent samples t-test. 
a
 Significant effect of age 
(p<0.05). 
b
 Significant effect of treatment in middle-aged animals (p=0.03). 
 
 
 
Young Middle-aged 
Sham ECS Sham ECS 
Variabl
e 
Pre-
treatm
ent 
Post-
treatm
ent 
Chan
ge 
Pre-
treatm
ent 
Post-
treatm
ent 
Chan
ge 
Pre-
treatm
ent 
Post-
treatm
ent 
Chan
ge 
Pre-
treatm
ent 
Post-
treatm
ent 
Chan
ge 
U-
CORT 
(nmol/2
4h) 
2.05 
(0.64) 
2.61 
(0.69) 
0.563 
(0.68
2) 
1.87 
(0.42) 
2.49 
(0.54) 
0.621 
(0.54
7) 
2.61 
(0.78) 
a
 
2.61 
(0.73) 
a
 
0.000
5 
(0.48
1) 
2.68 
(0.82)
 
a
 
3.81 
(1.63) 
a
 
1.135 
(1.59
8) 
b
 
U-8-
oxodG 
(nmol/2
4h) 
0.10 
(0.02) 
0.13 
(0.04) 
0.026 
(0.02
1) 
0.11 
(0.03) 
0.12 
(0.02) 
0.017 
(0.03
7) 
0.11 
(0.02) 
0.13 
(0.03) 
0.03 
(0.03
) 
0.13 
(0.04) 
0.15 
(0.06) 
0.019 
(0.02
8) 
U-8-
oxoGuo 
(nmol/2
4h) 
0.41 
(0.08) 
0.50 
(0.09) 
0.084 
(0.05
1) 
0.44 
(0.10) 
0.51 
(0.08) 
0.073 
(0.11
9) 
0.44 
(0.06) 
0.45 
(0.10) 
0.02 
(0.09
) 
0.47 
(0.06) 
0.54 
(0.10) 
0.072 
(0.11
8) 
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